Circulation. 2009;119:e211-e219
Published online before print December 23, 2008,
doi: 10.1161/CIRCULATIONAHA.108.792952
(Circulation. 2009;119:e211-e219.)
© 2009 American Heart Association, Inc.
Percutaneous Balloon Mitral Valvuloplasty
A Review
Masakiyo Nobuyoshi, MD;
Takeshi Arita, MD;
Shin-ichi Shirai, MD;
Naoya Hamasaki, MD;
Hiroyoshi Yokoi, MD;
Masashi Iwabuchi, MD;
Hitoshi Yasumoto, MD;
Hideyuki Nosaka, MD
From Kokura Memorial Hospital (M.N., T.A., S.S., H. Yokoi, M.I. H. Yasumoto, H.N.) and Hamasaki Cardiology Clinic (N.H.), Kitakyushu, Japan.
Correspondence to Masakiyo Nobuyoshi, MD, Department of Cardiology, Kokura Memorial Hospital, 1–1, Kifune-cho, Kokura-kitaku, Kitakyushu, Japan. E-mail kmhptca@kokura-heart.com
Key Words: balloon valvuloplasty echocardioagraphy mitral valve mitral valve stenosis rheumatic heart disease
An extract of the first 250 words of the full text is provided, because this article has no abstract.
|
 |
Introduction
|
|---|
Several diseases have been acknowledged as pathological causes
for mitral valve stenosis (MS), of which rheumatic heart disease
is the most prevalent. Rheumatic heart disease is a chronic
manifestation of rheumatic carditis, which occurs in 60% to
90% of cases of rheumatic fever. Rheumatic fever is a late sequela
to Group A β-hemolytic streptococcal infection of the throat.
The initial rheumatic fever results only in an edematous inflammatory
process, leading to the fibrinoid necrosis of the connective
tissue and cellular reactions. The initial valvulitis results
in verruciform deposition of fibrin along the closing portion
of the leaflets. Although all of the cardiac valves may be involved
by this rheumatic process, the mitral valve is involved most
prominently. The endocardial lesion most often leaves permanent
sequela resulting in valvular regurgitation, stenosis, or both.
Stenosis of this valve occurs from leaflet thickening, commissural
fusion, and chordal shortening/fusion due to the above described
pathological process.
 |
Rheumatic Heart Valve Disease Is Still Epidemic in Asia
|
|---|
The decrease of the incidence of rheumatic heart disease in
developed countries had already begun in 1910, and it is now
below 1.0 per 100 000. On the other hand, the occurrence rate
of rheumatic heart disease in developing countries remains substantial.
Because the decline in the prevalence of rheumatic fever in
industrialized nations started even before the era of penicillin
and thus was related to improved living standards, the continued
prevalence of rheumatic heart disease in undeveloped or developing
countries is related not only to the limited availability of
penicillin but to their socioeconomic status (ie, overpopulation,
. . . [Full Text of this Article]